KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Assets (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Other Non-Current Assets for 11 consecutive years, with $25.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets rose 11.58% year-over-year to $25.7 million, compared with a TTM value of $25.7 million through Sep 2025, up 11.58%, and an annual FY2024 reading of $22.3 million, down 10.88% over the prior year.
  • Other Non-Current Assets was $25.7 million for Q3 2025 at Medpace Holdings, up from $23.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $25.7 million in Q3 2025 and bottomed at $13.1 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $20.3 million, with a median of $20.8 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets skyrocketed 98.11% in 2021, then dropped 17.12% in 2024.
  • Year by year, Other Non-Current Assets stood at $17.4 million in 2021, then increased by 21.28% to $21.1 million in 2022, then grew by 18.18% to $25.0 million in 2023, then fell by 10.88% to $22.3 million in 2024, then grew by 15.59% to $25.7 million in 2025.
  • Business Quant data shows Other Non-Current Assets for MEDP at $25.7 million in Q3 2025, $23.8 million in Q2 2025, and $21.5 million in Q1 2025.